Medicine and Dentistry
Breast Cancer
100%
Neoplasm
37%
Cancer Risk
28%
Carbon 11
26%
Radioactive Tracer
26%
Breast Reconstruction
25%
Choline
25%
Thyroid Cancer
25%
BRCA1
24%
Positron Emission Tomography-Computed Tomography
24%
Contralateral
22%
Mammography
21%
Ovarian Cancer
21%
Primary Hyperparathyroidism
20%
Recurrent Disease
19%
Diagnosis
18%
Bevacizumab
18%
Body Mass Index
18%
Parathyroid Adenoma
18%
Mastectomy
18%
Quadrantectomy
18%
Methionine
17%
Positron Emission Tomography
17%
Meta-Analysis
17%
Specific Tumor
17%
Differentiated Thyroid Cancer
17%
Positron Emission Tomography
17%
Scatter Factor Receptor
17%
Papillary Thyroid Cancer
17%
Sentinel Lymph Node Biopsy
17%
Quality of Life
17%
Odds Ratio
15%
Population
14%
Parathyroid
14%
Overall Survival
13%
Breast Cancer Screening
10%
Breast Tumor
10%
Iodine 131
10%
Vasculotropin A
10%
Clinical Management
10%
Lymph Node
10%
Diagnostic Performance
10%
Short Form 36
9%
Physical Examination
9%
Family History
9%
Breast Lesion
9%
Assessment of Margin
9%
Low Drug Dose
9%
Microdosing
8%
Cohort Effect
8%
Keyphrases
Breast Cancer Susceptibility Gene 1 (BRCA1)
17%
Breast Cancer
13%
Fluorescence Imaging
12%
Breast
12%
Molecular Fluorescence
11%
Overall Survival
11%
Primary Breast Cancer
11%
Early Breast Cancer
10%
Fluorescent Tracer
10%
Quality of Life
9%
Histopathological Features
8%
Germline Pathogenic Variant
8%
BRCA2
8%
Risk-reducing Salpingo-oophorectomy
8%
Breast Cancer Mortality
8%
Application Model
8%
4DCT
8%
Central Lymph Node
8%
Ablative
8%
Oncoplastic Breast Surgery
8%
Papillary Thyroid Cancer
8%
BREAST-Q
8%
Skeletal muscle Radiodensity
8%
DIEP Flap Breast Reconstruction
8%
Mutation Carriers
8%
Tumor-specific
8%
Hospital Follow-up
8%
Iodine Scan
8%
Nodal Metastasis
8%
Complication Rate
8%
Smoke Effect
8%
Hyperfunctioning Parathyroid Gland
8%
Patient Beliefs
8%
Fluorescence Spectroscopy
8%
Drug Screening
8%
Differentiated Thyroid Carcinoma
8%
Contralateral Breast
8%
Primary Hyperparathyroidism (pHPT)
8%
Head-to-head Comparison
8%
Breast Cancer Follow-up
8%
Clinical Management
8%
Receptor Targets
8%
Body Mass Index
8%
Radiation Risk
8%
In-breast Recurrence
8%
Web-based Nomogram
8%
Early Age of Onset
8%
Analytical Framework
8%
11C-choline PET
8%
External Beam Radiotherapy
8%
